<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>63(7)</volume><submitter>Iddins BO</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>The COVID-19 pandemic jeopardizes continuity of operations of workplaces and the health and safety of workers. Exemplar workplace-related SARS-CoV-2 benchmarks are described and illustrated with empirical data.&lt;h4>Methods&lt;/h4>Benchmarks were collected over a 9-month period on a large workplace (N = 5500+). These ranged from quantitative indices associated with RT-qPCR targeted testing and random surveillance screening, surveillance for new variants of SARS-CoV-2, intensive contact tracing, case management, return to work procedures, to monitoring of antibody seropositive status.&lt;h4>Results&lt;/h4>Data and analyses substantiated effectiveness of interventions. This was evidenced in suppressed infection rates, rapid case identification and isolation, acceptance of the program </pubmed_abstract><journal>Journal of occupational and environmental medicine</journal><pagination>548-556</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8247538</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Benchmarking SARS CoV-2 Infection in the Workplace to Support Continuity of Operations.</pubmed_title><pmcid>PMC8247538</pmcid><pubmed_authors>Iddins BO</pubmed_authors><pubmed_authors>Buck B</pubmed_authors><pubmed_authors>Waugh MH</pubmed_authors><pubmed_authors>Cato T</pubmed_authors><pubmed_authors>Shourbaji R</pubmed_authors><pubmed_authors>Wesh C</pubmed_authors><pubmed_authors>Graham DE</pubmed_authors><pubmed_authors>Attia K</pubmed_authors><pubmed_authors>Jones D</pubmed_authors><pubmed_authors>Partin A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Benchmarking SARS CoV-2 Infection in the Workplace to Support Continuity of Operations.</name><description>&lt;h4>Objective&lt;/h4>The COVID-19 pandemic jeopardizes continuity of operations of workplaces and the health and safety of workers. Exemplar workplace-related SARS-CoV-2 benchmarks are described and illustrated with empirical data.&lt;h4>Methods&lt;/h4>Benchmarks were collected over a 9-month period on a large workplace (N = 5500+). These ranged from quantitative indices associated with RT-qPCR targeted testing and random surveillance screening, surveillance for new variants of SARS-CoV-2, intensive contact tracing, case management, return to work procedures, to monitoring of antibody seropositive status.&lt;h4>Results&lt;/h4>Data and analyses substantiated effectiveness of interventions. This was evidenced in suppressed infection rates, rapid case identification and isolation, acceptance of the program </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2025-04-04T12:34:14.231Z</modification><creation>2022-02-10T18:25:44.197Z</creation></dates><accession>S-EPMC8247538</accession><cross_references><pubmed>33741830</pubmed><doi>10.1097/JOM.0000000000002188</doi></cross_references></HashMap>